首页 > 最新文献

Annals of surgery最新文献

英文 中文
Artificial Intelligence in Surgical Outcomes Reporting: The Next Best Thing, or Just Artificially Intelligent "Garbage In, Garbage Out"? 手术结果报告中的人工智能:下一个最好的东西,还是仅仅是人工智能GIGO?
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2025-12-01 Epub Date: 2025-06-13 DOI: 10.1097/SLA.0000000000006789
Fariba Abbassi, Jeffrey Barkun
{"title":"Artificial Intelligence in Surgical Outcomes Reporting: The Next Best Thing, or Just Artificially Intelligent \"Garbage In, Garbage Out\"?","authors":"Fariba Abbassi, Jeffrey Barkun","doi":"10.1097/SLA.0000000000006789","DOIUrl":"10.1097/SLA.0000000000006789","url":null,"abstract":"","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"897-899"},"PeriodicalIF":6.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Randomized, Single-Center, Superiority Trial of Radioactive Seed Localization Versus Wire Localization for Malignant Breast Disease. 一项随机、单中心、放射性种子定位与导线定位治疗恶性乳腺疾病的优越性试验。
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2025-12-01 Epub Date: 2024-05-24 DOI: 10.1097/SLA.0000000000006356
Lejla Hadzikadic-Gusic, Jessica Bilz, Danielle Boselli, James Symanowski, Michelle Wallander, Laura Danile, Amy Sobel, Chad Livasy, Terry Sarantou, Amy Voci, Deba Sarma, Meghan Forster, Shirley Scott, Whitney Mitchelides, Sapana Shah, Xhevahire Begic, Cecilia Flynn, Allison Verbyla, Adilen Cruz, Almira Sejdic, Courtney Schepel, Richard L White

Objective: Compare radioactive seed localization (RSL) and wire-guided localization (WL) for nonpalpable malignant breast disease.

Background: While WL has been the most common approach for localization of nonpalpable breast tumors, other techniques such as RSL, intraoperative ultrasound, radioactive intraoperative occult lesion localization, hematoma localization, radar localization, and magnetic seed localization have been suggested as safe and efficacious alternatives. However, very few randomized controlled trials have compared these localization techniques.

Methods: Between July 2015 and January 2021, 400 women with nonpalpable malignant breast disease were randomized 1:1 to RSL or WL, stratified by the surgeon and invasive disease status. The primary outcome was initial resection negative margin rates. Secondary outcomes included time efficiencies, cost, and satisfaction.

Results: There was no significant difference in negative margin rates between RSL and WL [RSL 0.80 (95% CI: 0.75-0.86) vs WL 0.85 (95% CI: 0.80-0.89); P=0.29]. RSL received better patient scores for anxiety [OR=2.62 (95% CI: 1.79-3.84); P<0.01], pain [OR=2.50 (95% CI: 1.69-3.71); P<0.01], and overall satisfaction [OR=3.24 (95% CI: 1.70-6.22); P<0.01] compared with WL. Radiologists and surgeons associated RSL with better convenience [OR=3.32 (95% CI: 1.65-6.69); P<0.01] and satisfaction of surgical procedure conduct [OR=1.67 (95% CI: 1.09-2.58); P=0.02]. Time in radiology did not differ [RSL mean (SD) 12.8±9.5 min vs. WL 11.4±6.0 min; P=0.18]. RSL incurred a $600 higher cost than WL.

Conclusions: The results of the largest randomized controlled trial in the United States support RSL as an acceptable alternative to WL in the treatment of nonpalpable malignant breast disease. While RSL was not superior to WL in achievement of negative margins, patients and providers reported improved satisfaction scores.

目的:比较放射性粒子定位(RSL)与线导定位(WL)在乳腺不可摸恶性疾病中的应用。背景:虽然WL是乳腺不可触及肿瘤最常用的定位方法,但其他技术如RSL、术中超声、术中放射性隐匿病灶定位、血肿定位、雷达定位和磁粒定位等也被认为是安全有效的替代方法。然而,很少有随机对照试验比较这些定位技术。方法:2015年7月至2021年1月期间,400名不可触及的恶性乳腺疾病女性按外科医生和侵袭性疾病状态按1:1随机分为RSL或WL。主要结果是初始切除阴性切缘率。次要结果包括时间效率、成本和满意度。结果:RSL和WL之间的负切缘率无显著差异[RSL 0.80 (95% CI: 0.75-0.86) vs WL 0.85 (95% CI: 0.80-0.89);P = 0.29)。RSL患者在焦虑方面得分更高[OR=2.62 (95% CI: 1.79-3.84);结论:美国最大的随机对照试验的结果支持RSL作为一种可接受的替代WL治疗不可触及的恶性乳腺疾病。虽然RSL在实现负边际方面并不优于WL,但患者和提供者报告的满意度得分有所提高。
{"title":"A Randomized, Single-Center, Superiority Trial of Radioactive Seed Localization Versus Wire Localization for Malignant Breast Disease.","authors":"Lejla Hadzikadic-Gusic, Jessica Bilz, Danielle Boselli, James Symanowski, Michelle Wallander, Laura Danile, Amy Sobel, Chad Livasy, Terry Sarantou, Amy Voci, Deba Sarma, Meghan Forster, Shirley Scott, Whitney Mitchelides, Sapana Shah, Xhevahire Begic, Cecilia Flynn, Allison Verbyla, Adilen Cruz, Almira Sejdic, Courtney Schepel, Richard L White","doi":"10.1097/SLA.0000000000006356","DOIUrl":"10.1097/SLA.0000000000006356","url":null,"abstract":"<p><strong>Objective: </strong>Compare radioactive seed localization (RSL) and wire-guided localization (WL) for nonpalpable malignant breast disease.</p><p><strong>Background: </strong>While WL has been the most common approach for localization of nonpalpable breast tumors, other techniques such as RSL, intraoperative ultrasound, radioactive intraoperative occult lesion localization, hematoma localization, radar localization, and magnetic seed localization have been suggested as safe and efficacious alternatives. However, very few randomized controlled trials have compared these localization techniques.</p><p><strong>Methods: </strong>Between July 2015 and January 2021, 400 women with nonpalpable malignant breast disease were randomized 1:1 to RSL or WL, stratified by the surgeon and invasive disease status. The primary outcome was initial resection negative margin rates. Secondary outcomes included time efficiencies, cost, and satisfaction.</p><p><strong>Results: </strong>There was no significant difference in negative margin rates between RSL and WL [RSL 0.80 (95% CI: 0.75-0.86) vs WL 0.85 (95% CI: 0.80-0.89); P=0.29]. RSL received better patient scores for anxiety [OR=2.62 (95% CI: 1.79-3.84); P<0.01], pain [OR=2.50 (95% CI: 1.69-3.71); P<0.01], and overall satisfaction [OR=3.24 (95% CI: 1.70-6.22); P<0.01] compared with WL. Radiologists and surgeons associated RSL with better convenience [OR=3.32 (95% CI: 1.65-6.69); P<0.01] and satisfaction of surgical procedure conduct [OR=1.67 (95% CI: 1.09-2.58); P=0.02]. Time in radiology did not differ [RSL mean (SD) 12.8±9.5 min vs. WL 11.4±6.0 min; P=0.18]. RSL incurred a $600 higher cost than WL.</p><p><strong>Conclusions: </strong>The results of the largest randomized controlled trial in the United States support RSL as an acceptable alternative to WL in the treatment of nonpalpable malignant breast disease. While RSL was not superior to WL in achievement of negative margins, patients and providers reported improved satisfaction scores.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"282 6","pages":"998-1006"},"PeriodicalIF":6.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12594132/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145494209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Management of T1 Colon Cancer in Denmark: A Nationwide Cohort Study. 丹麦目前对 T1 结肠癌的管理:全国队列研究
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2025-12-01 Epub Date: 2024-05-27 DOI: 10.1097/SLA.0000000000006355
Anders L Ebbehøj, Lars N Jørgensen, Henry G Smith, Peter-Martin Krarup

Objective: To describe the management of T1 colon cancer in a retrospective study of a national cancer registry.

Background: There is increasing interest in the potential of local excision (LE) as an organ-preserving treatment for early colon cancer. However, accurate identification of patients who may have lymph node metastases (LNM) and require further surgery is a major challenge.

Methods: Patients diagnosed with T1 colon cancer in Denmark from 2016 to 2020 were included and divided according to treatment: polypectomy (referred to as LE), upfront colectomy, and completion colectomy. The primary outcome was the proportion of patients diagnosed with LE. Secondary outcomes included the rate of LNM, the association of histopathological risk factors with LNM, and overall survival.

Results: A total of 1749 patients were included, and 1022 patients (58.4%) underwent initial LE. The rate of R1 margins after the initial LE was 31.0%. Colectomy was performed in 1160 patients (upfront in 727, completion in 433), of whom 58.3% had pT1 cancer. The rate of LNM was 11.5%. Rates of LNM were similar in patients undergoing upfront or completion colectomy (10.2% vs 12.4%, P = 0.392) and in patients with any single histopathological risk factor compared with those with none (8.9% vs 10.6%, P = 0.565). Although overall survival was significantly shorter in patients undergoing LE alone, no association between survival and treatment strategy was found in multivariable analysis.

Conclusions: LE is the most common mode of diagnosis in patients with T1 colon cancer and does not negatively impact survival and postoperative outcomes. Current strategies to stratify patients to complete surgery appear insufficient, and more robust predictors are needed.

目的: 描述一项全国癌症登记处回顾性研究中对 T1 结肠癌的处理情况:描述一项全国癌症登记处回顾性研究中对 T1 结肠癌的处理情况:背景:人们越来越关注局部切除术(LE)作为早期结肠癌保留器官治疗的潜力。然而,准确识别可能存在淋巴结转移(LNM)并需要进一步手术的患者是一项重大挑战:方法:纳入2016年至2020年在丹麦确诊为T1结肠癌的患者,并根据治疗方法进行分类:息肉切除术(简称LE)、前期结肠切除术和完全结肠切除术。主要结果是通过LE诊断的患者比例。次要结果包括LNM发生率、组织病理学风险因素与LNM的关系以及总生存率:共纳入 1,749 名患者,其中 1,022 名患者(58.4%)接受了初次 LE。初次结肠切除术后R1边缘率为31.0%。1,160名患者接受了结肠切除术(727名患者接受了前期切除术,433名患者接受了结肠切除术),其中58.3%的患者为pT1癌。LNM发生率为11.5%。在接受前期或完成期结肠切除术的患者中,LNM发生率相似(10.2% vs 12.4%,P=0.392),在有任何单一组织病理学危险因素的患者中,LNM发生率与无任何单一组织病理学危险因素的患者相似(8.9% vs 10.6%,P=0.565)。虽然单纯 LE 患者的总生存期明显较短,但多变量分析并未发现生存期与治疗策略之间存在关联:结论:LE是T1结肠癌患者最常见的诊断方式,不会对生存率和术后效果产生负面影响。目前对完成手术的患者进行分层的策略似乎不够充分,需要更可靠的预测指标。
{"title":"Current Management of T1 Colon Cancer in Denmark: A Nationwide Cohort Study.","authors":"Anders L Ebbehøj, Lars N Jørgensen, Henry G Smith, Peter-Martin Krarup","doi":"10.1097/SLA.0000000000006355","DOIUrl":"10.1097/SLA.0000000000006355","url":null,"abstract":"<p><strong>Objective: </strong>To describe the management of T1 colon cancer in a retrospective study of a national cancer registry.</p><p><strong>Background: </strong>There is increasing interest in the potential of local excision (LE) as an organ-preserving treatment for early colon cancer. However, accurate identification of patients who may have lymph node metastases (LNM) and require further surgery is a major challenge.</p><p><strong>Methods: </strong>Patients diagnosed with T1 colon cancer in Denmark from 2016 to 2020 were included and divided according to treatment: polypectomy (referred to as LE), upfront colectomy, and completion colectomy. The primary outcome was the proportion of patients diagnosed with LE. Secondary outcomes included the rate of LNM, the association of histopathological risk factors with LNM, and overall survival.</p><p><strong>Results: </strong>A total of 1749 patients were included, and 1022 patients (58.4%) underwent initial LE. The rate of R1 margins after the initial LE was 31.0%. Colectomy was performed in 1160 patients (upfront in 727, completion in 433), of whom 58.3% had pT1 cancer. The rate of LNM was 11.5%. Rates of LNM were similar in patients undergoing upfront or completion colectomy (10.2% vs 12.4%, P = 0.392) and in patients with any single histopathological risk factor compared with those with none (8.9% vs 10.6%, P = 0.565). Although overall survival was significantly shorter in patients undergoing LE alone, no association between survival and treatment strategy was found in multivariable analysis.</p><p><strong>Conclusions: </strong>LE is the most common mode of diagnosis in patients with T1 colon cancer and does not negatively impact survival and postoperative outcomes. Current strategies to stratify patients to complete surgery appear insufficient, and more robust predictors are needed.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"1110-1117"},"PeriodicalIF":6.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141154417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing the Management Strategies of Delayed Postpancreaticoduodenectomy Hemorrhage: Lessons From 2013 Consecutive Pancreaticoduodenectomies. 优化胰十二指肠切除术后迟发性出血的处理策略:2013年连续胰十二指肠切除术的经验
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2025-12-01 Epub Date: 2024-04-22 DOI: 10.1097/SLA.0000000000006306
Tao Ma, Tao Qian, Kaiquan Huang, Huiliang Li, Wei-Chiao Lin, Mengyi Lao, Shunliang Gao, Xueli Bai, Tingbo Liang

Objective: To optimize the management strategies of delayed postpancreaticoduodenectomy hemorrhage (PPH) by evaluating data from a high-volume pancreatic center.

Background: Delayed PPH is a potentially lethal complication. The management of delayed PPH remains controversial.

Methods: Patients who underwent pancreaticoduodenectomy between July 2018 and June 2023 were identified from an institutional database. The clinical scenarios, management, and outcomes of patients with delayed PPH (>5 days postoperatively) were analyzed.

Results: Of the 2013 patients who underwent elective pancreaticoduodenectomy, 130 (6.5%) with delayed PPH were identified. The overall mortality was 15.4%. The success rates of endoscopy, angiographic intervention, and relaparotomy in treating delayed PPH were 54.5%, 56.5%, and 68.8%, respectively. For PPH from the hepatic arteries or their branches, complete blockade of the common or proper hepatic artery (C/PHA) was performed in 17 patients, either by coil embolization (n=7) or surgical ligation (n=10). Coil embolization of the C/PHA resulted in significant infarction of the left liver in 2 patients. No postoperative liver infarction occurred in patients who underwent ligation of the C/PHA during relaparotomy. Ten patients underwent suture repair of the C/PHA 13 times during relaparotomy. Arterial ligation achieved a significantly higher success rate of hemostasis than suture repair of the C/PHA during relaparotomy (100% vs 30.8%, P <0.001).

Conclusions: Angiography should be attempted first in managing hemodynamically stable delayed PPH. Arterial ligation was preferred for bleeding from the hepatic arteries during relaparotomy with minor consequences for the liver.

目的:通过对大容量胰腺中心数据的评估,优化延迟性胰十二指肠切除术后出血(PPH)的治疗策略。摘要背景资料:迟发性PPH是一种潜在的致命并发症。延迟PPH的管理仍然存在争议。方法:从机构数据库中确定2018年7月至2023年6月期间接受胰十二指肠切除术的患者。分析迟发性PPH患者(术后50 ~ 50 d)的临床情况、处理及预后。结果:在2013例接受择期胰十二指肠切除术的患者中,有130例(6.5%)被确定为迟发性PPH。总死亡率为15.4%。内窥镜、血管造影干预和开腹手术治疗迟发性PPH的成功率分别为54.5%、56.5%和68.8%。对于来自肝动脉或其分支的PPH, 17例患者通过线圈栓塞(n=7)或手术结扎(n=10)完全阻断肝总动脉或肝固有动脉(C/PHA)。C/PHA线圈栓塞导致2例左肝明显梗死。在再开腹术中结扎C/PHA的患者无术后肝梗死发生。10例患者在再开腹术中进行了13次C/PHA缝合修复。再开腹术中,动脉结扎术的止血成功率明显高于C/PHA缝合修复术(100% vs. 30.8%)。结论:对于血流动力学稳定的迟发性PPH,应首先尝试血管造影。动脉结扎是首选的肝动脉出血在再开腹术中对肝脏的轻微后果。
{"title":"Optimizing the Management Strategies of Delayed Postpancreaticoduodenectomy Hemorrhage: Lessons From 2013 Consecutive Pancreaticoduodenectomies.","authors":"Tao Ma, Tao Qian, Kaiquan Huang, Huiliang Li, Wei-Chiao Lin, Mengyi Lao, Shunliang Gao, Xueli Bai, Tingbo Liang","doi":"10.1097/SLA.0000000000006306","DOIUrl":"10.1097/SLA.0000000000006306","url":null,"abstract":"<p><strong>Objective: </strong>To optimize the management strategies of delayed postpancreaticoduodenectomy hemorrhage (PPH) by evaluating data from a high-volume pancreatic center.</p><p><strong>Background: </strong>Delayed PPH is a potentially lethal complication. The management of delayed PPH remains controversial.</p><p><strong>Methods: </strong>Patients who underwent pancreaticoduodenectomy between July 2018 and June 2023 were identified from an institutional database. The clinical scenarios, management, and outcomes of patients with delayed PPH (>5 days postoperatively) were analyzed.</p><p><strong>Results: </strong>Of the 2013 patients who underwent elective pancreaticoduodenectomy, 130 (6.5%) with delayed PPH were identified. The overall mortality was 15.4%. The success rates of endoscopy, angiographic intervention, and relaparotomy in treating delayed PPH were 54.5%, 56.5%, and 68.8%, respectively. For PPH from the hepatic arteries or their branches, complete blockade of the common or proper hepatic artery (C/PHA) was performed in 17 patients, either by coil embolization (n=7) or surgical ligation (n=10). Coil embolization of the C/PHA resulted in significant infarction of the left liver in 2 patients. No postoperative liver infarction occurred in patients who underwent ligation of the C/PHA during relaparotomy. Ten patients underwent suture repair of the C/PHA 13 times during relaparotomy. Arterial ligation achieved a significantly higher success rate of hemostasis than suture repair of the C/PHA during relaparotomy (100% vs 30.8%, P <0.001).</p><p><strong>Conclusions: </strong>Angiography should be attempted first in managing hemodynamically stable delayed PPH. Arterial ligation was preferred for bleeding from the hepatic arteries during relaparotomy with minor consequences for the liver.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"1076-1082"},"PeriodicalIF":6.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145184588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive Biases and Heuristics in Surgical Settings: A Systematic Review. 认知偏差和启发式在外科设置:系统回顾。
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2025-12-01 Epub Date: 2025-04-21 DOI: 10.1097/SLA.0000000000006736
Holly Aylmore, Srishti Agarwal, Hani J Marcus, Anand S Pandit

Objective: To identify cognitive biases and heuristics experienced by surgeons in operative settings and the impact these biases and heuristics have on patient care.

Background: Cognitive biases and heuristics are systematic errors in thinking that can affect clinical decisions. Both are noted in surgical settings and are a risk to patient safety.

Methods: This review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and PROSPERO registered (CRD42023432099). Five major databases were searched from inception to August 28, 2022, with an updated search on January 27, 2024. Original primary research studies in English were included, with relevant risk of bias tools employed for each study.

Results: Twenty-one papers were included. Thirty-eight biases were identified across 6 experiments, 5 analyses, and 10 survey studies. Confirmation bias, anchoring, risk aversion, and overconfidence bias were the most represented. Risk of bias was moderate across most studies. Cognitive biases and heuristics were found to influence surgical outcomes and 6 studies cited a negative impact on patient care, with one associating biases with fatal outcomes.

Conclusions: Biases and heuristics contribute to surgical errors and never events, and will continue to do so until they are recognised and addressed. Implementing debiasing strategies, such as mindfulness training and deliberate reflection, was found to reduce surgical errors in 2 studies. This review highlights the need for experimental studies, which are essential for understanding how and why biases lead to negative outcomes and for evaluating further debiasing interventions. We propose directions for future research and system changes.

目的:本系统综述旨在识别外科医生在手术环境中经历的认知偏差和启发式,以及这些偏差和启发式对患者护理的影响。摘要背景资料:认知偏差和启发式是思维中的系统性错误,可以影响临床决策。这两种情况在外科手术中都很常见,对患者安全构成威胁。方法:本综述按照PRISMA指南和PROSPERO注册(CRD42023432099)进行。五个主要数据库从成立到2022年8月28日进行了搜索,并于2024年1月27日进行了更新搜索。纳入了英语原始的主要研究,并为每项研究使用了相关的偏倚风险工具。结果:共纳入21篇论文。在6个实验、5个分析和10个调查研究中发现了38个偏差。确认偏误、锚定、风险厌恶和过度自信偏误是最具代表性的。大多数研究的偏倚风险为中等。发现认知偏差和启发式影响手术结果,六项研究引用了对患者护理的负面影响,其中一项将偏差与致命结果联系起来。结论:偏见和启发式有助于手术错误和永远不会发生的事件,并将继续这样做,直到他们被认识和解决。两项研究发现,实施正念训练和刻意反思等消除偏见的策略可以减少手术错误。这篇综述强调了实验研究的必要性,这对于理解偏见如何以及为什么会导致负面结果以及评估进一步的消除偏见干预措施至关重要。提出了未来的研究方向和制度变革。
{"title":"Cognitive Biases and Heuristics in Surgical Settings: A Systematic Review.","authors":"Holly Aylmore, Srishti Agarwal, Hani J Marcus, Anand S Pandit","doi":"10.1097/SLA.0000000000006736","DOIUrl":"10.1097/SLA.0000000000006736","url":null,"abstract":"<p><strong>Objective: </strong>To identify cognitive biases and heuristics experienced by surgeons in operative settings and the impact these biases and heuristics have on patient care.</p><p><strong>Background: </strong>Cognitive biases and heuristics are systematic errors in thinking that can affect clinical decisions. Both are noted in surgical settings and are a risk to patient safety.</p><p><strong>Methods: </strong>This review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and PROSPERO registered (CRD42023432099). Five major databases were searched from inception to August 28, 2022, with an updated search on January 27, 2024. Original primary research studies in English were included, with relevant risk of bias tools employed for each study.</p><p><strong>Results: </strong>Twenty-one papers were included. Thirty-eight biases were identified across 6 experiments, 5 analyses, and 10 survey studies. Confirmation bias, anchoring, risk aversion, and overconfidence bias were the most represented. Risk of bias was moderate across most studies. Cognitive biases and heuristics were found to influence surgical outcomes and 6 studies cited a negative impact on patient care, with one associating biases with fatal outcomes.</p><p><strong>Conclusions: </strong>Biases and heuristics contribute to surgical errors and never events, and will continue to do so until they are recognised and addressed. Implementing debiasing strategies, such as mindfulness training and deliberate reflection, was found to reduce surgical errors in 2 studies. This review highlights the need for experimental studies, which are essential for understanding how and why biases lead to negative outcomes and for evaluating further debiasing interventions. We propose directions for future research and system changes.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"946-953"},"PeriodicalIF":6.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12594140/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143953964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative Pancreatic Fistula After Pancreatoduodenectomy: Can Radiomics Improve Clinical Risk Scores? 胰十二指肠切除术后胰瘘:放射组学能提高临床风险评分吗?
IF 9 1区 医学 Q1 SURGERY Pub Date : 2025-11-28 DOI: 10.1097/sla.0000000000006991
Ankur P Choubey,Josephine Magnin,Johan Gagnière,Abhishek Midya,John A Steinharter,Rikiya Yamashita,Thomas Boerner,Richard K G Do,Kevin C Soares,Mithat Gonen,Jeffrey A Drebin,T Peter Kingham,Vinod P Balachandran,Michael I D'Angelica,Alice C Wei,Amber L Simpson,Jayasree Chakraborty,William R Jarnagin
OBJECTIVEAssess the potential added benefit of radiomics to clinical models for predicting postoperative pancreatic fistula (POPF) after pancreatoduodenectomy (PD).SUMMARY OF BACKGROUND DATARadiomics extracts quantitative data from medical imaging based on enhancement patterns. Clinical applications of radiomics have been investigated in pancreas, lung, breast, and prostate cancers.METHODSThis single center retrospective study included all patients with available preoperative CT scan before PD from 2009-2021. Radiomic features that reflect heterogeneity in enhancement patterns were extracted from manually segmented future remnant pancreas. Clinical variables and radiomic features were used with random forest classifier to design five predictive models for grade B/C clinically relevant POPF (CR-POPF): preoperative (PreClin), intraoperative (IntraClin), radiomics alone (Rad), PreClin with radiomics (PreClin-Rad), and IntraClin with radiomics (IntraClin-Rad). Training data was randomly selected and comprised 70% (n=339) of the cohort, and the remaining 30% (n=145) was the test set. A prospective validation cohort (n=60) was also created.RESULTSFrom 1855 eligible PD, all 234 with POPF were included, random sampling was used on the remainder to select 250 without POPF. In the test set, PreClin (AUC=0.74), IntraClin (AUC=0.78), and Rad (AUC=0.75) performed similarly. Best results were noted with combined models, AUC=0.82 for PreClin-Rad and AUC=0.84 for IntraClin-Rad. The same patterns were noted in the prospective validation cohort with PreClin-Rad performing best (AUC=0.78).CONCLUSIONRadiomics compared favorably with clinical risk scores for CR-POPF after PD, and combined models with radiomics and clinical data offer the strongest prediction. The PreClin-Rad model demonstrates the greatest clinical utility with excellent predictive outcomes relying entirely on preoperative data in the test and prospective validation cohorts.
目的评估放射组学在预测胰十二指肠切除术(PD)术后胰瘘(POPF)的临床模型中的潜在附加益处。放射组学基于增强模式从医学影像中提取定量数据。放射组学的临床应用已经在胰腺癌、肺癌、乳腺癌和前列腺癌中进行了研究。方法本研究为单中心回顾性研究,纳入2009-2021年所有PD术前CT扫描的患者。从人工分割的未来残余胰腺中提取反映增强模式异质性的放射学特征。利用临床变量和放射学特征,采用随机森林分类器设计5个B/C级临床相关POPF (CR-POPF)预测模型:术前(precin)、术中(IntraClin)、单独放射组学(Rad)、precin联合放射组学(preclinr -Rad)、IntraClin联合放射组学(IntraClin-Rad)。训练数据随机选取,占队列的70% (n=339),其余30% (n=145)为测试集。还建立了一个前瞻性验证队列(n=60)。结果1855例符合条件的PD中,有POPF的234例全部入选,其余未有POPF的250例采用随机抽样。在测试集中,precin (AUC=0.74)、IntraClin (AUC=0.78)和Rad (AUC=0.75)的表现相似。联合模型效果最好,preclinr - rad的AUC=0.82, IntraClin-Rad的AUC=0.84。在前瞻性验证队列中也发现了相同的模式,其中preclind - rad表现最佳(AUC=0.78)。结论放射组学对PD后CR-POPF的预测优于临床风险评分,结合放射组学和临床数据的模型预测效果最好。在试验和前瞻性验证队列中,preclind - rad模型显示出最大的临床效用,具有出色的预测结果,完全依赖于术前数据。
{"title":"Postoperative Pancreatic Fistula After Pancreatoduodenectomy: Can Radiomics Improve Clinical Risk Scores?","authors":"Ankur P Choubey,Josephine Magnin,Johan Gagnière,Abhishek Midya,John A Steinharter,Rikiya Yamashita,Thomas Boerner,Richard K G Do,Kevin C Soares,Mithat Gonen,Jeffrey A Drebin,T Peter Kingham,Vinod P Balachandran,Michael I D'Angelica,Alice C Wei,Amber L Simpson,Jayasree Chakraborty,William R Jarnagin","doi":"10.1097/sla.0000000000006991","DOIUrl":"https://doi.org/10.1097/sla.0000000000006991","url":null,"abstract":"OBJECTIVEAssess the potential added benefit of radiomics to clinical models for predicting postoperative pancreatic fistula (POPF) after pancreatoduodenectomy (PD).SUMMARY OF BACKGROUND DATARadiomics extracts quantitative data from medical imaging based on enhancement patterns. Clinical applications of radiomics have been investigated in pancreas, lung, breast, and prostate cancers.METHODSThis single center retrospective study included all patients with available preoperative CT scan before PD from 2009-2021. Radiomic features that reflect heterogeneity in enhancement patterns were extracted from manually segmented future remnant pancreas. Clinical variables and radiomic features were used with random forest classifier to design five predictive models for grade B/C clinically relevant POPF (CR-POPF): preoperative (PreClin), intraoperative (IntraClin), radiomics alone (Rad), PreClin with radiomics (PreClin-Rad), and IntraClin with radiomics (IntraClin-Rad). Training data was randomly selected and comprised 70% (n=339) of the cohort, and the remaining 30% (n=145) was the test set. A prospective validation cohort (n=60) was also created.RESULTSFrom 1855 eligible PD, all 234 with POPF were included, random sampling was used on the remainder to select 250 without POPF. In the test set, PreClin (AUC=0.74), IntraClin (AUC=0.78), and Rad (AUC=0.75) performed similarly. Best results were noted with combined models, AUC=0.82 for PreClin-Rad and AUC=0.84 for IntraClin-Rad. The same patterns were noted in the prospective validation cohort with PreClin-Rad performing best (AUC=0.78).CONCLUSIONRadiomics compared favorably with clinical risk scores for CR-POPF after PD, and combined models with radiomics and clinical data offer the strongest prediction. The PreClin-Rad model demonstrates the greatest clinical utility with excellent predictive outcomes relying entirely on preoperative data in the test and prospective validation cohorts.","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"48 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145613227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inpatient Palliative Care and Post-operative Healthcare Utilization Among Older Surgical Patients. 老年外科患者住院姑息治疗和术后医疗保健利用。
IF 9 1区 医学 Q1 SURGERY Pub Date : 2025-11-27 DOI: 10.1097/sla.0000000000006990
Orly N Farber,Hiba Dhanani,Mengyuan Ruan,Masami Tabata-Kelly,Cameron Comrie,Amanda J Reich,Kate Sciacca,Tamryn F Gray,Lyle Suh,Stuart R Lipsitz,Elizabeth J Lilley,Christine S Ritchie,Charlotta Lindvall,Zara Cooper
OBJECTIVETo determine associations between documented palliative care processes and changes in post-discharge healthcare utilization among a cohort of seriously ill older adults after common major elective surgeries.SUMMARY BACKGROUND DATANational guidelines recommend palliative care processes for patients with serious illness undergoing major surgery. However, outcomes associated with palliative care delivery to elective surgical patients are understudied.METHODSWe conducted a retrospective, multicenter study using Natural Language Processing to identify electronic health record documentation of five palliative care processes in a cohort of older adults with serious illness who underwent one of five major elective surgeries in a large regional health system between 2016-2018. The processes included: (1) Goals of care conversation, (2) Code status limitation, (3) Palliative care consultation, (4) Hospice assessment, and (5) Surrogate decision-maker designation. We used Medicare claims to assess healthcare utilization one-year post-discharge.RESULTSAmong 1,082 patients, 54.1% had a documented surrogate decision-maker, 4.3% had code status limitations, 2.6% had goals of care conversations, and<2.0% had assessment for hospice or palliative care consultations. In adjusted analysis, patients with documented surrogate decision-maker had no significant changes in hospital days, days at home, or ED visits in the year following surgery. Patients who had documented code status limitations alone spent significantly fewer days at home than those who did not (314.9 vs. 338.6, P=0.004).CONCLUSIONSInpatient palliative care processes such as surrogate decision maker-designation are not associated with changes in one-year healthcare utilization after elective surgery.
目的:确定一组重症老年人在普通重大选择性手术后姑息治疗过程与出院后医疗保健利用变化之间的关系。摘要背景:国家指南推荐对接受大手术的重症患者实施姑息治疗。然而,与选择性手术患者姑息治疗相关的结果尚未得到充分研究。方法:我们进行了一项回顾性的多中心研究,使用自然语言处理来识别2016-2018年期间在大型区域卫生系统中接受了五次主要选择性手术之一的严重疾病老年人队列中的五次姑息治疗过程的电子健康记录。流程包括:(1)疗护对话目标、(2)程式码状态限制、(3)缓和疗护谘询、(4)安宁疗护评估、(5)替代决策者指定。我们使用医疗保险索赔来评估出院后一年的医疗保健利用情况。结果在1082名患者中,54.1%有记录在案的替代决策者,4.3%有代码状态限制,2.6%有护理对话目标,<2.0%有临终关怀或姑息治疗咨询评估。在调整分析中,有记录的替代决策者的患者在手术后一年的住院天数、在家天数或急诊科就诊时间没有显著变化。单独记录代码状态限制的患者比没有记录代码状态限制的患者在家的天数明显减少(314.9 vs. 338.6, P=0.004)。结论患者姑息治疗过程(如指定替代决策者)与择期手术后一年医疗保健利用的变化无关。
{"title":"Inpatient Palliative Care and Post-operative Healthcare Utilization Among Older Surgical Patients.","authors":"Orly N Farber,Hiba Dhanani,Mengyuan Ruan,Masami Tabata-Kelly,Cameron Comrie,Amanda J Reich,Kate Sciacca,Tamryn F Gray,Lyle Suh,Stuart R Lipsitz,Elizabeth J Lilley,Christine S Ritchie,Charlotta Lindvall,Zara Cooper","doi":"10.1097/sla.0000000000006990","DOIUrl":"https://doi.org/10.1097/sla.0000000000006990","url":null,"abstract":"OBJECTIVETo determine associations between documented palliative care processes and changes in post-discharge healthcare utilization among a cohort of seriously ill older adults after common major elective surgeries.SUMMARY BACKGROUND DATANational guidelines recommend palliative care processes for patients with serious illness undergoing major surgery. However, outcomes associated with palliative care delivery to elective surgical patients are understudied.METHODSWe conducted a retrospective, multicenter study using Natural Language Processing to identify electronic health record documentation of five palliative care processes in a cohort of older adults with serious illness who underwent one of five major elective surgeries in a large regional health system between 2016-2018. The processes included: (1) Goals of care conversation, (2) Code status limitation, (3) Palliative care consultation, (4) Hospice assessment, and (5) Surrogate decision-maker designation. We used Medicare claims to assess healthcare utilization one-year post-discharge.RESULTSAmong 1,082 patients, 54.1% had a documented surrogate decision-maker, 4.3% had code status limitations, 2.6% had goals of care conversations, and<2.0% had assessment for hospice or palliative care consultations. In adjusted analysis, patients with documented surrogate decision-maker had no significant changes in hospital days, days at home, or ED visits in the year following surgery. Patients who had documented code status limitations alone spent significantly fewer days at home than those who did not (314.9 vs. 338.6, P=0.004).CONCLUSIONSInpatient palliative care processes such as surrogate decision maker-designation are not associated with changes in one-year healthcare utilization after elective surgery.","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"21 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145609917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender-Affirming Vaginoplasty Improves Quality of Life in Transfeminine Individuals: A Single-Center Prospective Study. 性别确认阴道成形术改善跨性别个体的生活质量:一项单中心前瞻性研究。
IF 9 1区 医学 Q1 SURGERY Pub Date : 2025-11-27 DOI: 10.1097/sla.0000000000006988
Caleb Haley,Cole V Roblee,Gaines Blasdel,Jennifer B Hamill,Emily Sluiter,Shelby Svientek,Peter Mankowski,Lauren Marquette,Jessica J Hsu,Pasithorn A Suwanabol,Edwin G Wilkins,Megan Lane,Shane D Morrison,William M Kuzon
OBJECTIVETo longitudinally evaluate patient-reported outcomes following gender-affirming vaginoplasty across multiple physical and psychosocial health domains.SUMMARY BACKGROUND DATAVaginoplasty is a frequently accessed genital gender-affirming surgery by transfeminine individuals. Few studies have prospectively examined patient-reported outcomes following this procedure.METHODSA prospective, longitudinal patient-reported outcome survey study of patients undergoing gender-affirming vaginoplasty was conducted from September 2018 to February 2023 at a single institution. The primary outcomes of this study were fifteen validated patient-reported outcome measure scales across various health domains completed at three survey timepoints: preoperatively, 3-months postoperatively, and 12-months postoperatively. Individuals who completed the surveys at all three timepoints were included for final analysis.RESULTSResponse rate was 55% with 48 total participants. There was significant postoperative improvement in mental health outcomes as measured by the Patient Health Questionnaire-9 (PHQ-9) and General Anxiety Disorder-7 (GAD-7) scales. The Gender Congruence and Life Satisfaction Scale (GCLS) scores as well as the BODY-Q Body Image, Social Function, and Satisfaction with Decision scales all significantly improved postoperatively compared to preoperatively. Patient-Reported Outcomes Measurement Information System (PROMIS) Pain scales demonstrated worsened pain at 3-months postoperatively but returned to preoperative levels at 12-months postoperatively. PROMIS Sexual Function scales also improved postoperatively compared to preoperatively. Minor complications did not worsen 12-month patient-reported outcomes. Major complications and mental health diagnoses were associated with worse patient-reported outcomes across a variety of scales.CONCLUSIONSFollowing gender-affirming vaginoplasty, transfeminine individuals report significant improvement across a wide variety of validated patient-reported outcome measures assessing physical and psychosocial health domains.
目的:纵向评估性别确认阴道成形术后患者报告的多个生理和心理健康领域的结果。摘要背景资料阴道成形术是跨女性个体经常使用的生殖器性别确认手术。很少有研究前瞻性地检查了该手术后患者报告的结果。方法2018年9月至2023年2月在一家医院对接受性别确认阴道成形术的患者进行了一项前瞻性、纵向患者报告的结果调查研究。本研究的主要结果是在三个调查时间点(术前、术后3个月和术后12个月)完成了15个经过验证的患者报告的不同健康领域的结果测量量表。在所有三个时间点完成调查的个人被纳入最终分析。结果共48人,有效率为55%。通过患者健康问卷-9 (PHQ-9)和一般焦虑障碍-7 (GAD-7)量表测量,术后心理健康结果有显著改善。性别一致性和生活满意度量表(GCLS)得分以及Body - q身体形象、社会功能和决策满意度量表在术后均较术前显著改善。患者报告结果测量信息系统(PROMIS)疼痛量表显示术后3个月疼痛加重,但术后12个月恢复到术前水平。与术前相比,术后PROMIS性功能量表也有所改善。轻微并发症没有恶化患者报告的12个月预后。在各种量表中,主要并发症和心理健康诊断与较差的患者报告结果相关。结论:在性别确认阴道成形术后,跨性别个体报告在各种经过验证的患者报告的评估身体和心理健康领域的结果测量中有显着改善。
{"title":"Gender-Affirming Vaginoplasty Improves Quality of Life in Transfeminine Individuals: A Single-Center Prospective Study.","authors":"Caleb Haley,Cole V Roblee,Gaines Blasdel,Jennifer B Hamill,Emily Sluiter,Shelby Svientek,Peter Mankowski,Lauren Marquette,Jessica J Hsu,Pasithorn A Suwanabol,Edwin G Wilkins,Megan Lane,Shane D Morrison,William M Kuzon","doi":"10.1097/sla.0000000000006988","DOIUrl":"https://doi.org/10.1097/sla.0000000000006988","url":null,"abstract":"OBJECTIVETo longitudinally evaluate patient-reported outcomes following gender-affirming vaginoplasty across multiple physical and psychosocial health domains.SUMMARY BACKGROUND DATAVaginoplasty is a frequently accessed genital gender-affirming surgery by transfeminine individuals. Few studies have prospectively examined patient-reported outcomes following this procedure.METHODSA prospective, longitudinal patient-reported outcome survey study of patients undergoing gender-affirming vaginoplasty was conducted from September 2018 to February 2023 at a single institution. The primary outcomes of this study were fifteen validated patient-reported outcome measure scales across various health domains completed at three survey timepoints: preoperatively, 3-months postoperatively, and 12-months postoperatively. Individuals who completed the surveys at all three timepoints were included for final analysis.RESULTSResponse rate was 55% with 48 total participants. There was significant postoperative improvement in mental health outcomes as measured by the Patient Health Questionnaire-9 (PHQ-9) and General Anxiety Disorder-7 (GAD-7) scales. The Gender Congruence and Life Satisfaction Scale (GCLS) scores as well as the BODY-Q Body Image, Social Function, and Satisfaction with Decision scales all significantly improved postoperatively compared to preoperatively. Patient-Reported Outcomes Measurement Information System (PROMIS) Pain scales demonstrated worsened pain at 3-months postoperatively but returned to preoperative levels at 12-months postoperatively. PROMIS Sexual Function scales also improved postoperatively compared to preoperatively. Minor complications did not worsen 12-month patient-reported outcomes. Major complications and mental health diagnoses were associated with worse patient-reported outcomes across a variety of scales.CONCLUSIONSFollowing gender-affirming vaginoplasty, transfeminine individuals report significant improvement across a wide variety of validated patient-reported outcome measures assessing physical and psychosocial health domains.","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"41 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145609919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Surgical Association 2025: Inclusive Excellence in Politically Divided Times. 美国外科协会2025:政治分裂时代的包容性卓越。
IF 9 1区 医学 Q1 SURGERY Pub Date : 2025-11-26 DOI: 10.1097/sla.0000000000006985
Dana A Telem,Selwyn O Rogers,Anna Kirkland,Gilbert R Upchurch,Jeffrey B Matthews
{"title":"American Surgical Association 2025: Inclusive Excellence in Politically Divided Times.","authors":"Dana A Telem,Selwyn O Rogers,Anna Kirkland,Gilbert R Upchurch,Jeffrey B Matthews","doi":"10.1097/sla.0000000000006985","DOIUrl":"https://doi.org/10.1097/sla.0000000000006985","url":null,"abstract":"","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"117 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145599698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Dexamethasone-Enriched Tumescent Anesthesia for Radiofrequency Ablation of GSV insufficiency: A Double-Blind Randomized Clinical Trial. 地塞米松强化肿胀麻醉对射频消融GSV功能不全的影响:一项双盲随机临床试验。
IF 9 1区 医学 Q1 SURGERY Pub Date : 2025-11-21 DOI: 10.1097/sla.0000000000006987
Yuwei Xiang,Xinyan Wang,Jing Huang,Jing Xu,Li Wang,Zhoupeng Wu,Hankui Hu,Fei Xiong,Huanrui Hu,Yukui Ma
OBJECTIVETo evaluate whether dexamethasone enriched tumescent local anesthesia (TLA) fluid reduces post-operative pain and improves recovery outcomes following radiofrequency ablation(RFA) for great saphenous vein (GSV) insufficiency.SUMMARY OF BACKGROUND DATAPost-operative pain and local complications of RFA for GSV insufficiency remain significant concerns. Identifying strategies to improve patient outcomes is critical for optimizing care.METHODSDouble-blind, randomized clinical trial was conducted. Adult patients with GSV insufficiency classified as CEAP C2-C5 were included. The treatment group received dexamethasone enriched TLA fluid, while the control group received traditional TLA fluid. Standard RFA procedures were performed in both groups. The primary outcome was post-operative pain measured by the Visual Analogue Scale (VAS). Secondary outcomes included quality of life (EQ-VAS, EQ-5D), Venous Clinical Severity Score (VCSS), local complications, and GSV occlusion rates.RESULTSA total of 136 patients were randomized (67 treatment group, 69 control group). Median pain scores on day 1 and 3 were significantly lower in the treatment group compared to the control group [1 (IQR: 0-2) vs. 2 (IQR: 1-3), P=0.010; 0 (IQR: 0-1) vs. 1 (IQR: 0-2), P=0.007]. Ecchymosis incidence was reduced in the treatment group (58.7% vs. 75.4%; P=0.042). No significant differences were observed in VCSS scores, EQ-5D scores, thrombosis incidence, or GSV occlusion rates.CONCLUSIONSDexamethasone enriched TLA fluid during RFA reduces early postoperative pain and ecchymosis without increasing complications. This approach offers a cost-effective enhancement to RFA protocols for non-diabetic patients.
目的评价地塞米松增强肿胀局麻(TLA)液是否能减轻大隐静脉(GSV)不全射频消融(RFA)术后疼痛和改善恢复效果。背景资料RFA治疗GSV功能不全的术后疼痛和局部并发症仍然值得关注。确定改善患者预后的策略对于优化护理至关重要。方法采用双盲、随机临床试验。成人GSV功能不全分为CEAP C2-C5。治疗组给予地塞米松强化TLA液治疗,对照组给予传统TLA液治疗。两组均行标准射频消融术。主要观察指标为术后疼痛视觉模拟评分(VAS)。次要结局包括生活质量(EQ-VAS、EQ-5D)、静脉临床严重程度评分(VCSS)、局部并发症和GSV闭塞率。结果共136例患者随机分为治疗组67例,对照组69例。治疗组第1、3天疼痛中位评分明显低于对照组[1 (IQR: 0-2) vs. 2 (IQR: 1-3), P=0.010;0 (IQR: 0-1) vs. 1 (IQR: 0-2), P=0.007]。治疗组瘀斑发生率降低(58.7% vs. 75.4%; P=0.042)。VCSS评分、EQ-5D评分、血栓发生率或GSV闭塞率均无显著差异。结论在RFA中应用地塞米松增强TLA液可减轻术后早期疼痛和瘀斑,且未增加并发症。这种方法为非糖尿病患者的RFA方案提供了一种经济有效的增强。
{"title":"Impact of Dexamethasone-Enriched Tumescent Anesthesia for Radiofrequency Ablation of GSV insufficiency: A Double-Blind Randomized Clinical Trial.","authors":"Yuwei Xiang,Xinyan Wang,Jing Huang,Jing Xu,Li Wang,Zhoupeng Wu,Hankui Hu,Fei Xiong,Huanrui Hu,Yukui Ma","doi":"10.1097/sla.0000000000006987","DOIUrl":"https://doi.org/10.1097/sla.0000000000006987","url":null,"abstract":"OBJECTIVETo evaluate whether dexamethasone enriched tumescent local anesthesia (TLA) fluid reduces post-operative pain and improves recovery outcomes following radiofrequency ablation(RFA) for great saphenous vein (GSV) insufficiency.SUMMARY OF BACKGROUND DATAPost-operative pain and local complications of RFA for GSV insufficiency remain significant concerns. Identifying strategies to improve patient outcomes is critical for optimizing care.METHODSDouble-blind, randomized clinical trial was conducted. Adult patients with GSV insufficiency classified as CEAP C2-C5 were included. The treatment group received dexamethasone enriched TLA fluid, while the control group received traditional TLA fluid. Standard RFA procedures were performed in both groups. The primary outcome was post-operative pain measured by the Visual Analogue Scale (VAS). Secondary outcomes included quality of life (EQ-VAS, EQ-5D), Venous Clinical Severity Score (VCSS), local complications, and GSV occlusion rates.RESULTSA total of 136 patients were randomized (67 treatment group, 69 control group). Median pain scores on day 1 and 3 were significantly lower in the treatment group compared to the control group [1 (IQR: 0-2) vs. 2 (IQR: 1-3), P=0.010; 0 (IQR: 0-1) vs. 1 (IQR: 0-2), P=0.007]. Ecchymosis incidence was reduced in the treatment group (58.7% vs. 75.4%; P=0.042). No significant differences were observed in VCSS scores, EQ-5D scores, thrombosis incidence, or GSV occlusion rates.CONCLUSIONSDexamethasone enriched TLA fluid during RFA reduces early postoperative pain and ecchymosis without increasing complications. This approach offers a cost-effective enhancement to RFA protocols for non-diabetic patients.","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"25 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145559043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1